1-2 of 2
Rudolf A. de Boer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Free
Silvio E. Inzucchi, Kieran F. Docherty, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez, Piotr Ponikowski, Marc S. Sabatine, Scott D. Solomon, Subodh Verma, Jan Bělohlávek, Michael Böhm, Chern-En Chiang, Rudolf A. de Boer, Mirta Diez, Andre Dukát, Charlotta E.A. Ljungman, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Pardeep S. Jhund, John J.V. McMurray
Journal: Diabetes Care
Diabetes Care 2021;44(2):586–594
https://doi.org/10.2337/dc20-1675
Published: 18 December 2020
View articletitled, Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF
Open the PDF for Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF in another window
Journal Articles

Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable Coronary Artery Disease: Data from the Heart and Soul Study

Open Access
Joost P. van Melle, MD, PHD, Mariska Bot, MSC, Peter de Jonge, PHD, Rudolf A. de Boer, MD, PHD, Dirk J. van Veldhuisen, MD, PHD, Mary A. Whooley, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(9):2084–2089
https://doi.org/10.2337/dc10-0286
Published: 01 September 2010
View articletitled, Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable Coronary Artery Disease: Data from the Heart and Soul Study
Open the PDF for Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable Coronary Artery Disease: Data from the Heart and Soul Study in another window